Apraclonidine

FDA Drug Profile — Apraclonidine

Apraclonidine is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Apraclonidine. Available dosage form: solution.

Drug details

Generic Name
Apraclonidine
Brand Names
Apraclonidine
Application Number
NDA020258
Sponsor
Sandoz Inc
NDC Codes
1
Dosage Forms
SOLUTION
Routes
OPHTHALMIC
Active Ingredients
APRACLONIDINE HYDROCHLORIDE

Indications and Usage

INDICATIONS AND USAGE Apraclonidine ophthalmic solution 0.5% is indicated for short-term adjunctive therapy, in patients on maximally tolerated medical therapy, who require additional IOP reduction. Patients on maximally tolerated medical therapy, who are treated with apraclonidine ophthalmic solution 0.5% to delay surgery, should have frequent follow-up examinations and treatment should be discontinued if the IOP rises significantly. The addition of apraclonidine ophthalmic solution 0.5% to patients already using two aqueous suppressing drugs (i.e., beta-blocker plus carbonic anhydrase inhibitor) as part of their maximally tolerated medical therapy may not provide additional benefit. This is because apraclonidine ophthalmic solution 0.5% is an aqueous suppressing drug and the addition of a third aqueous suppressant may not significantly reduce IOP. The IOP lowering efficacy of apraclonidine ophthalmic solution 0.5% diminishes over time in some patients. This loss of effect, or tachyphylaxis, appears to be an individual occurrence with a variable time of onset and should be closely monitored. The benefit for most patients is less than one month.

Warnings

WARNINGS Not for injection or oral ingestion. FOR EYE USE ONLY.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.